The Ovarian Cancer Market is undergoing rapid transformation as healthcare providers and pharmaceutical companies accelerate the development of advanced treatment strategies aimed at improving patient outcomes. Ovarian cancer remains one of the leading causes of cancer-related mortality among women, primarily due to delayed diagnosis and disease recurrence. Continuous advancements in molecular...